Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces
18F-FDG
ABT-737
Cancer metabolism
acute myeloid leukemia
all trans retinoic acid (ATRA)
apoptosis
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
4
11
2020
medline:
28
4
2021
entrez:
3
11
2020
Statut:
ppublish
Résumé
Acute myeloid leukemia (AML) is a malignant disease of the bone marrow, comprising various subtypes. We have investigated seven different AML cell lines that showed different sensitivities toward the inducer of apoptosis ABT-737, with IC
Identifiants
pubmed: 33140666
doi: 10.1080/10428194.2020.1839648
doi:
Substances chimiques
ABT-737
0
Biphenyl Compounds
0
Nitrophenols
0
Piperazines
0
Sulfonamides
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Tretinoin
5688UTC01R
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
630-639Commentaires et corrections
Type : CommentIn